- kleinishere parentjust encountered these in a local public library a week ago. toddlers loved them.
- Encountered these miniature wood marble runs in Switzerland. Still on my “wish list.” Sounds like you may enjoy them, too.
- Link to blog post? Didn’t see it on quick look at your site.
- Feature request - a way to filter by age / difficulty from the home page. I see it on individual pages but didn’t quickly see the age listed as a tag. This is a point of friction on most coloring page sites. Congrats on this. I have bookmarked it. Thank you
For others who stumble upon this, another good free site without too many ads:
- What stack? Are you considering a TUI overlay to make it remarkably efficient?
- Didn’t realize this was available.
Similarly published by OpenAI: https://status.openai.com/
30 day comparisons as of writing:
99.61% for Claude.ai 99.22% for ChatGPT
99.92% for Claude APIs 99.25% for OpenAI APIs
Obviously not apples to apples and somewhat up to discretion of what triggers an impact. We’re clearly not at 99.99% yet.
- Came here to find this. MANY upvotes.
I used Doom for a couple months.
Then started considering a vanilla eMacs. I started taking notes on packages I found highly recommended and interesting.
Then I found this. And the author has done all that work and then made it into a “let me walk through a config” including a lot of the most recommended packages and sensible configs.
Gives you the lesson of building a config, knowing what’s in your config, and then being fluent in changing it.
He also has more notes on his blog about the packages + more : https://www.jamescherti.com/essential-emacs-packages/
And I now feel comfortable making changes myself.
- Phenomenal. Thank you.
- For the many posters recommending BPA free paper - does anyone have suggestions / a link for a reliable seller?
I looked on Amazon after another receipt printer post on HN but couldn’t find anything that provided confidence in the BPA characterization. ULINE is quantities are absurd for personal use. Imagine their most be a decent alternative but never see any named.
- Xenodium is doing amazing things for emacs. If you enjoy this or are generally emacs interested, I’d check out his blog @ https://xenodium.com/
I also purchased my first iOS app upon recommendation from other emacs users - the author’s app, Journelly. A simple portable place to save down links or notes and export out as org files (as one option; apparently markdown is on the way). https://xenodium.com/journelly-for-ios
No affiliation to Xenodium. I’ve just been diving into emacs this year and love seeing his contributions.
- Potentially inhibiting IL-6 or reducing Lp(a). We'll get an early glimpse from some robust Phase 3's next year. These have been in the works for several years with tens of thousands of patients enrolled - it'll be an exciting set of readouts.
Novo Nordisk purchased Corvidia Therapeutics in 2020 [1] for their IL-6 antibody and will read out the first of three Phase 3's in 2026 [2]. Their programs, however, are focused on individuals with higher risk factors like chronic kidney disease (2026 topline), a couple kinds of heart failure (2027), and a prior myocardial infarction (heart attack; 2027). These trials notably are on top of "standard of care" existing therapies, so they're looking for additional benefit beyond what is commonly sought, like LDL reduction (highlighted in other comments).
Novartis recently announced an intended acquisition of Tourmaline Bio for their IL-6 antibody [3]. So attention to the biological target is heating up.
Another target mentioned in the comments is Lp(a). Genetic studies suggest a heightened risk of cardiovascular disease. Therapeutics aimed at reducing Lp(a) levels are being explored separate from IL-6 for a similar end goal of avoiding cardiovascular events (i.e. heart attacks, death).
Novartis will read out a Phase 3 of an Lp(a) reducing therapeutic in the first half of 2026 [4]. Amgen will likely read out theirs likely sometime thereafter [5]. These have been a long time coming: Amgen in-licensed their asset from Arrowhead in 2016 [6], Novartis in-licensed their asset from Ionis/Akcea in 2017 [7].
If any of these work, there's a chance that they'd be explored in patients with less pronounced risk than the original studies in these Phase 3's. Amgen has already announced an intent to explore their Lp(a) drug in a Phase 3 with participants with elevated Lp(a) at "high risk" for a first cardiovascular event in 2H25/1H26.
[1] https://ml-eu.globenewswire.com/Resource/Download/e7e162e5-a... [2] Page 113 - https://cdn.ipaper.io/iPaper/Files/ffd0326c-1fa6-41e5-a82d-0... Page 225 - https://investor.novonordisk.com/q2presentation2025/?page=22... [3] https://ir.tourmalinebio.com/news-releases/news-release-deta... [4] https://ir.ionis.com/static-files/66c5e90a-3651-480d-a596-1c..., https://clinicaltrials.gov/study/NCT04023552 [5] https://clinicaltrials.gov/study/NCT05581303?rank=1, Page 15 - https://investors.amgen.com/static-files/27fcb898-9cee-48db-... [6] https://www.amgen.com/newsroom/press-releases/2016/09/amgen-... [7] https://ir.ionis.com/news-releases/news-release-details/ioni...
- Have you stuck with Doom/Space and evil key bindings or been pulled over to a more vanilla setup?
- Correct. And confirmed by Kodak on their Facebook page. The “going concern” disclosure is an accounting requirement. However, the company claims to have line of sight toward addressing it.
https://www.facebook.com/share/p/19UdGkBYwr/?mibextid=wwXIfr
Also discussed on Reddit.
- This is great - thank you! Hadn't seen the blog post or the MOOC. Appreciate the resources.
- What packages and workflow specifically do you use? I haven’t come across many gentle introductions so looking for clues on what’s a reasonable first step that’s well maintained with good docs.
- What specific features / functions are most compelling for lists? Of course moving a tree around with different header levels. But anything specifically great with lists?
- Are there any keywords that help with identifying the most clean/neutral paper? Went down the rabbit hole briefly and had a tough time feeling confident in what was credibly Bpa free (at least on Amazon).
- Nice to see this on HN from the app creator. Intrigued to try it (vs BeOrg) after seeing coverage at irreal, one of my usual emacs oriented blogs.
- Love these Kindle dashboards and thank you for the excellent write up. If you did anything notable with refresh rates and cron tab for battery life management (or if that’s simply unnecessary), that may be useful to note in the blog post. Given you’re monitoring frequent bus times, I suspect it may have come up.
- Was considering the same. Any GitHub link? If not, what LLM and what kind of pipeline? (If you can share!)
- Based on your experience, what age do you think is ideal for introducing the books to kids?
- He also offers 20EUR/hr eMacs coaching. For those jumping in or graduating to a new level.
- This is such a beautiful comment.
My 4yo child recently received a $10 digital camera at a generous birthday party and independently has figured out how to take videos (in addition to photos). Some self interviews, some videos of his sibling, his family. It really is amazing to see things from his eyes.
- Preserving family moments with a 35mm film camera and the attachment an analog photograph engenders vs. digital.
After seeing a friend with young kids post candid photos of his family for the last few years, I decided to give it a try. Purchased a Retina IIIc rangefinder camera (from the 1950s, preceded SLRs) and it's one of the most amazing purely mechanical, consumer-focused engineered products I've held in my hands. Got a scanner, successfully booted the Nikon Scan abandonware on a virtualized Windows XP environment, and saw my first roll of photos appear last weekend. Wife and extended family absolutely loved it. I've reviewed those 36 photos (standard roll length) more in the past week than the 1,000 family photos of the past 2 years on my cell phone. Excited for more.
- Talk about a great weekend outcome. The "can I see a sample post card?" is particularly powerful, and may deserve to be more prominent on your landing page. Like a left hand side text message chain/right hand side outcome of the postcard. Even an example of an actual printed one on a desk or in someone's hand could be nice.
Question - your privacy policy is fairly robust. Curious how you tackled this. Hire an attorney, skill set of yours, outsourced firm that does this for a nearly fixed price?
- Not an answer to your question, but interesting context for how eBooks work with libraries. And how not checking out a second time effectively is a loss of one “use” that may have directed the library to spend more on this book, rather than another. Sounds like you’re aware. Loved this Planet Money podcast
https://podcasts.apple.com/us/podcast/planet-money/id2907834...
- "personal account" - vs. the fund(s) an investor may work on as part of their day job
- The bespoke nature shines through in all the best ways. Thanks!
- Tech stack question -
Incredible website that is both feature rich and succinct to the content. As far as marketplaces go, there are some known platforms (e.g. ShareTribe) and payment options (e.g. Stripe Connect) - did you all "build" from the ground up or "buy" in putting this together?
- Can you elaborate on how you ended up selling the 2 businesses? Was it via in-bounds or using a marketplace for similar kinds of businesses?